Adaptive Biotechnologies (ADPT) Cash from Operations Growth (1y) (2019 - 2026)
Adaptive Biotechnologies (ADPT) Cash from Operations Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.89% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 14.65% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 86.90% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 25.34% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 25.96% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -9.63% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -14.10% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.33% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.74% |
| 10 | Adaptive Biotechnologies | 3.80 Bn | 3.58 Bn | 52.17 Mn | 66.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.52% |
| Dec 31, 2025 | 116.45% |
| Sep 30, 2025 | 73.67% |
| Jun 30, 2025 | 28.16% |
| Mar 31, 2025 | 25.73% |
| Dec 31, 2024 | 53.62% |
| Sep 30, 2024 | 42.03% |
| Jun 30, 2024 | 26.55% |
| Mar 31, 2024 | 35.16% |
| Dec 31, 2023 | 10.28% |
| Sep 30, 2023 | -10.08% |
| Jun 30, 2023 | 49.95% |
| Mar 31, 2023 | 8.22% |
| Dec 31, 2022 | 44.23% |
| Sep 30, 2022 | 2.38% |
| Jun 30, 2022 | -26.47% |
| Mar 31, 2022 | -10.66% |
| Dec 31, 2021 | -35.09% |
| Sep 30, 2021 | 7.87% |
| Jun 30, 2021 | -19.74% |